The global uridine monophosphate supplements market was valued at USD 310 million in 2024 and is projected to reach USD 610 million by 2035, registering a CAGR of 6.5% over the forecast period. Growth is fueled by rising health awareness, increasing disposable incomes, and the expansion of the nutraceutical sector. The demand for natural, brain-supportive supplements in both developed and emerging markets is further contributing to market expansion.